ARTICLE | Clinical News
Addex preclinical data
January 21, 2013 8:00 AM UTC
In a rat model of CMT1A, 10 mg/kg oral ADX71441 given every other day for 5 weeks followed by once-daily 5 mg/kg ADX71441 for 4 weeks down regulated PMP22 mRNA, reduced the number of hypo-myelinated a...